Pax Genes in Embryogenesis and Oncogenesis

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2008 Jul 17

PMID 18627422

Citations 65

Authors

Qiuyu Wang

Wen-Hui Fang

Jerzy Krupinski

Shant Kumar

Mark Slevin

Patricia Kumar

Affiliations

Soon will be listed here.

Abstract

The paired box genes are a family of nine developmental control genes, which in human beings (PAX) and mice (Pax) encode nuclear transcription factors. The temporal and spatial expressions of these highly conserved genes are tightly regulated during foetal development including organogenesis. PAX/Pax genes are switched off during the terminal differentiation of most structures. Specific mutations within a number of PAX/Pax genes lead to developmental abnormalities in both human beings and mice. Mutation in PAX3 causes Waardenburg syndrome, and craniofacial-deafness-hand syndrome. The Splotch phenotype in mouse exhibits defects in neural crest derivatives such as, pigment cells, sympathetic ganglia and cardiac neural crest-derived structures. The PAX family also plays key roles in several human malignancies. In particular, PAX3 is involved in rhabdomyosarcoma and tumours of neural crest origin, including melanoma and neuroblastoma. This review critically evaluates the roles of PAX/Pax in oncogenesis. It especially highlights recent advances in knowledge of how their genetic alterations directly interfere in the transcriptional networks that regulate cell differentiation, proliferation, migration and survival and may contribute to oncogenesis.

Citing Articles

Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care.

Saenz Hinojosa S, Reyes-Silva C, Hosomichi K, Romero V Front Genet. 2025; 15():1354632.

PMID: 39850491 PMC: 11754966. DOI: 10.3389/fgene.2024.1354632.

The theory of massively repeated evolution and full identifications of cancer-driving nucleotides (CDNs).

Zhang L, Deng T, Liufu Z, Liu X, Chen B, Hu Z Elife. 2024; 13.

PMID: 39688960 PMC: 11651657. DOI: 10.7554/eLife.99340.

Clinical and Genetic Correlation in Neurocristopathies: Bridging a Precision Medicine Gap.

Chatzi D, Kyriakoudi S, Dermitzakis I, Manthou M, Meditskou S, Theotokis P J Clin Med. 2024; 13(8).

PMID: 38673496 PMC: 11050951. DOI: 10.3390/jcm13082223.

The presence and distribution of various genes in postnatal CLP-affected palatine tissue.

Goida J, Pilmane M Maxillofac Plast Reconstr Surg. 2024; 46(1):1.

PMID: 38227085 PMC: 10792134. DOI: 10.1186/s40902-024-00412-1.

Comparison of growth performance and related gene expression of muscle and fat from Landrace, Yorkshire, and Duroc and Woori black pigs.

Kim B, Min Y, Jeong Y, Ramani S, Lim H, Jo Y J Anim Sci Technol. 2023; 65(1):160-174.

PMID: 37093948 PMC: 10119462. DOI: 10.5187/jast.2022.e93.

References

Beckwith J, Kiviat N, Bonadio J . Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol. 1990; 10(1-2):1-36. DOI: 10.3109/15513819009067094. View

Bowen N, Logani S, Dickerson E, Kapa L, Akhtar M, Benigno B . Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2006; 104(2):331-7. DOI: 10.1016/j.ygyno.2006.08.052. View

Vogan K, Underhill D, Gros P . An alternative splicing event in the Pax-3 paired domain identifies the linker region as a key determinant of paired domain DNA-binding activity. Mol Cell Biol. 1996; 16(12):6677-86. PMC: 231670. DOI: 10.1128/MCB.16.12.6677. View

Aagaard L, Rossi J . RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev. 2007; 59(2-3):75-86. PMC: 1978219. DOI: 10.1016/j.addr.2007.03.005. View

Hostein I, Andraud-Fregeville M, Guillou L, Terrier-Lacombe M, Deminiere C, Ranchere D . Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens. Cancer. 2004; 101(12):2817-24. DOI: 10.1002/cncr.20711. View

Tsukamoto K, Nakamura Y, Niikawa N . Isolation of two isoforms of the PAX3 gene transcripts and their tissue-specific alternative expression in human adult tissues. Hum Genet. 1994; 93(3):270-4. DOI: 10.1007/BF00212021. View

Ryan G, Morris J, Rauscher 3rd F, Dressler G . Repression of Pax-2 by WT1 during normal kidney development. Development. 1995; 121(3):867-75. DOI: 10.1242/dev.121.3.867. View

Pellizzari L, Puppin C, Mariuzzi L, Saro F, Pandolfi M, Di Lauro R . PAX8 expression in human bladder cancer. Oncol Rep. 2006; 16(5):1015-20. View

Rodolfo M, Daniotti M, Vallacchi V . Genetic progression of metastatic melanoma. Cancer Lett. 2004; 214(2):133-47. DOI: 10.1016/j.canlet.2004.06.049. View

10.

Mayanil C, George D, Freilich L, Miljan E, Mania-Farnell B, McLone D . Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem. 2001; 276(52):49299-309. DOI: 10.1074/jbc.M107933200. View

11.

Schwab M . MYCN in neuronal tumours. Cancer Lett. 2004; 204(2):179-87. DOI: 10.1016/S0304-3835(03)00454-3. View

12.

Chi N, Epstein J . Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 2001; 18(1):41-7. DOI: 10.1016/s0168-9525(01)02594-x. View

13.

Brun T, Duhamel D, Hu He K, Wollheim C, Gauthier B . The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells. Oncogene. 2007; 26(29):4261-71. DOI: 10.1038/sj.onc.1210205. View

14.

Singh S, Tang H, Lee J, Saunders G . Truncation mutations in the transactivation region of PAX6 result in dominant-negative mutants. J Biol Chem. 1998; 273(34):21531-41. DOI: 10.1074/jbc.273.34.21531. View

15.

Li H, Wang Q, Li H, Kumar S, Parker C, Slevin M . PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN. Cancer Lett. 2007; 253(2):215-23. DOI: 10.1016/j.canlet.2007.01.020. View

16.

Chalepakis G, Goulding M, Read A, Strachan T, Gruss P . Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc Natl Acad Sci U S A. 1994; 91(9):3685-9. PMC: 43646. DOI: 10.1073/pnas.91.9.3685. View

17.

Kitamura T, Ido Kitamura Y, Funahashi Y, Shawber C, Castrillon D, Kollipara R . A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest. 2007; 117(9):2477-85. PMC: 1950461. DOI: 10.1172/JCI32054. View

18.

Maris J . The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr. 2005; 17(1):7-13. DOI: 10.1097/01.mop.0000150631.60571.89. View

19.

Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias J . B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Invest. 2007; 117(9):2602-10. PMC: 1950455. DOI: 10.1172/JCI30842. View

20.

Gerber J, Richter T, Kremmer E, Adamski J, Hofler H, Balling R . Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J Pathol. 2002; 197(3):293-7. DOI: 10.1002/path.1115. View